AbbVie Inc. (ABBV) Gross profit 2016–2025
AbbVie Inc. (ABBV) annual gross profit history from SEC filings — each fiscal year as reported.
$43.0BFY2025 · since FY2016: $19.8B → $43.0B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $43.0B | +8.9% |
| FY2024 | $39.4B | +16.3% |
| FY2023 | $33.9B | -16.6% |
| FY2022 | $40.6B | +4.9% |
| FY2021 | $38.8B | +27.4% |
| FY2020 | $30.4B | +17.8% |
| FY2019 | $25.8B | +3.2% |
| FY2018 | $25.0B | +18.2% |
| FY2017 | $21.2B | +6.9% |
| FY2016 | $19.8B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ABBV financial trends
ABBV RevenueABBV Net incomeABBV Net marginABBV Gross marginABBV Operating incomeABBV Operating marginABBV Operating cash flowABBV Free cash flowABBV Capital expendituresABBV Return on equityABBV Stock buybacksABBV Dividends paidABBV Total assetsABBV Total liabilitiesABBV Shareholders’ equityABBV overview →